Pine Bridge Investments, L.P. Ligand Pharmaceuticals Inc Transaction History

Pine Bridge Investments, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $14,462 - $16,500	208 New	208 $14,000
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $558,879 - $1.18 Million	-4,354 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $188,794 - $245,394	894 Added 25.84%	4,354 $1.2 Million
Q2 2018 Aug 09, 2018	SELL	$150.77 - $207.98 $25,932 - $35,772	-172 Reduced 4.74%	3,460 $717,000
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $557,847 - $734,862	-4,024 Reduced 52.56%	3,632 $600,000
Q4 2017 Feb 09, 2018	BUY	$128.36 - $147.04 $649,501 - $744,022	5,060 Added 194.92%	7,656 $1.05 Million
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $10,640 - $12,138	88 Added 3.51%	2,596 $353,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,508	2,508 $304,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.